Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Applicant’s election without traverse of the following species in the reply filed on 25 February 2026 is acknowledged:a compound represented by
PNG
media_image1.png
299
478
media_image1.png
Greyscale
wherein(A) X1 is C; (B) X2 is C; (C) X3 is C; (D) X4 is C; (E) X5 is C; (F) X6 is C; (G) X7 is C; (H) X8 is C; (I) X9 is C; (J) X10 is C; (K) X11 is C; (L) X12 is C; (M) X13 is C; (N) X14 is C; (O) X15 is C; (P) X16 is C; (Q) X17 is C; (R) Y1 is direct bond; (S) RA is hydrogen; (T) RB is hydrogen; (U) RC is hydrogen; (V) RD is hydrogen; (W) RE is hydrogen; (Y) RF is hydrogen; (Z) L1 is a direct bond; and (1) A is a 6-membered monocyclic ring, i.e.,
PNG
media_image2.png
287
234
media_image2.png
Greyscale
.
The Examiner notes that the elected species does not appear to satisfy the conditions recited in claim 1: “with the proviso that if Y1 and L1 are each a direct bond then at least one of RA and RB is a heterocyclic group, and at least one of the following conditions are true:
1) at least one of RC, RD, RE, and RF comprises a group which is not hydrogen or carbazole;
2) RC comprises a carbocyclic or heterocyclic group;
3) the compound comprises three carbazole groups” (emphasis added).
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
Claims 1-20 are rejected under 35 U.S.C. 102(a)(10 as being anticipated by Kwong et al. (U.S. Patent No. 10,109,799).
Kwong et al. discloses a compound, the corresponding use thereof said compound in an organic light-emitting device, and the corresponding use thereof said organic light-emitting device in a consumer product, characterized in that said compound is inclusive of the compound of the present formula I, as generally represented therein by
PNG
media_image3.png
170
287
media_image3.png
Greyscale
PNG
media_image4.png
220
248
media_image4.png
Greyscale
(column 4, line 8+; claim 2), and more specifically as represented by the specific formulae on pages 11-79 therein, as well as in claim 8. For instance, some examples therein Kwong et al. expressly illustrate an organic light-emitting device comprising a compound represented by
PNG
media_image5.png
222
249
media_image5.png
Greyscale
(column 247, line 1+), an organic light-emitting device comprising a compound represented by
PNG
media_image6.png
302
300
media_image6.png
Greyscale
(column 254, line 20).
Allowable Subject Matter
Assuming arguendo that applicants provide support for how the elected species (preceding paragraph 2) complies with the proviso recited in claim 1 (preceding paragraph 3), then the elected species would be allowable.
Prior Art
The following prior art made of record and not relied upon is considered pertinent to applicant’s disclosure of macrocyclic compounds and their corresponding use thereof in organic electroluminescent devices: U.S. Patent Application Publication No. 2023/0192636, which is the pre-grant publication corresponding to the present application and related applications: U.S. Patent Application Publication Nos. 2023/0192714, 2023/0192665, 2023/0192738, 2023/0192739, 2023/0200211, 2023/0200212, and 2023/0286989.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Geraldina Visconti whose telephone number is (571)272-1334. The examiner can normally be reached Monday-Friday, 8:00am-4:30pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark F Huff can be reached at 571-272-1385. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
GERALDINA VISCONTI
Primary Examiner
Art Unit 1737
/GERALDINA VISCONTI/Primary Examiner, Art Unit 1737